Even if your doctor said the drug was safe, manufacturers are responsible for providing adequate warnings
Mahmoud Nassar, MD, PhD, from the Department of Medicine, Division of Endocrinology, Diabetes and Metabolism at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, who was not involved in this research, noted the following about the study to Medical News Today : Using national Medicare data, the study employs a robust target trial emulation design and leverages rigorous propensity score matching to balance demographic and clinical factors
Sometimes, the manufacturer might suggest applying the patch to the arm, chest, or upper back, and others might recommend administration in the abdominal region
The bioavailability problem is real but nuanced